UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
41.24
-0.23 (-0.54%)
Jul 28, 2026, 12:23 PM EDT - Market open
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $2.01 billion as of July 28, 2026. Its market cap has increased by 129.95% in one year.
Market Cap
2.01B
Enterprise Value
2.05B
1-Year Change
129.95%
Ranking
Category
Stock Price
$41.24
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $2.01B, an increase of 1,004.47%. That is a compound annual growth rate of 29.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 2.01B | 83.26% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 2.05B |
| Palvella Therapeutics | 2.04B |
| Nanobiotix | 2.02B |
| Rapport Therapeutics | 1.99B |
| Precigen | 1.99B |
| Aurinia Pharmaceuticals | 1.98B |
| ADMA Biologics | 1.97B |
| Mesoblast | 1.95B |